Accendra Health, Inc. (ACH)
NYSE·Healthcare·Medical - Distribution
$3.79
+10.67%
Mkt Cap $261.42M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $713.43M | $708.97M | -0.63% | $0.22 | $0.21 | -4.55% | — | — |
| Q4 2025 Oct 30, 2025 | $714.79M | $697.26M | -2.45% | $0.23 | $0.25 | +8.70% | — | — |
| Q3 2025 Aug 11, 2025 | $2.37B | $681.92M | -71.28% | $0.27 | $0.26 | -3.70% | — | — |
| Q2 2025 May 8, 2025 | $2.74B | $2.63B | -3.80% | $0.20 | $0.23 | +15.00% | — | — |
| Q1 2025 Feb 28, 2025 | $2.68B | $2.70B | +0.78% | $0.53 | $0.55 | +3.77% | — | — |
| Q4 2024 Nov 4, 2024 | $2.73B | $2.72B | -0.28% | $0.40 | $0.42 | +5.00% | — | — |
| Q3 2024 Aug 2, 2024 | $2.65B | $2.67B | +0.93% | $0.33 | $0.36 | +9.09% | — | — |
| Q2 2024 May 3, 2024 | $2.61B | $2.61B | +0.12% | $0.17 | $0.19 | +11.76% | — | — |
| Q1 2024 Feb 20, 2024 | $2.67B | $2.66B | -0.49% | $0.68 | $0.69 | +1.47% | — | — |
| Q4 2023 Nov 3, 2023 | $2.58B | $2.59B | +0.54% | $0.36 | $0.44 | +22.22% | — | — |
| Q3 2023 Aug 4, 2023 | $2.49B | $2.56B | +2.90% | $0.16 | $0.18 | +12.50% | — | — |
| Q2 2023 May 5, 2023 | $2.40B | $2.52B | +4.95% | -$0.09 | $0.05 | +155.56% | — | — |
| Q1 2023 Feb 28, 2023 | $2.46B | $2.55B | +3.67% | $0.39 | $0.28 | -28.21% | — | — |
| Q4 2022 Nov 2, 2022 | $2.40B | $2.50B | +4.12% | $0.39 | $0.41 | +5.13% | — | — |
| Q3 2022 Aug 3, 2022 | $2.54B | $2.50B | -1.71% | $0.76 | $0.76 | +0.00% | — | — |
| Q2 2022 May 3, 2022 | $2.31B | $2.41B | +4.27% | $0.77 | $0.96 | +24.68% | — | — |
| Q1 2022 Feb 23, 2022 | $2.43B | $2.47B | +1.36% | $0.67 | $0.81 | +20.90% | — | — |
| Q4 2021 Nov 3, 2021 | $2.45B | $2.50B | +1.97% | $0.55 | $0.74 | +34.55% | — | — |
| Q3 2021 Aug 3, 2021 | $2.49B | $2.49B | +0.00% | $0.99 | $1.06 | +7.07% | — | — |
| Q2 2021 May 5, 2021 | $2.36B | $2.33B | -1.49% | $0.97 | $1.57 | +61.86% | — | — |